Please use this identifier to cite or link to this item:
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
- Biomanguinhos - Artigos de Periódicos [497]
- INI - Artigos de Periódicos [3646]
- IOC - Artigos de Periódicos [12979]
Metadata
Show full item record
IMPACT OF HIV-RELATED IMMUNE IMPAIRMENT OF YELLOW FEVER VACCINE IMMUNOGENICITY IN PEOPLE LIVING WITH HIV-ANRS 12403
Produção científica do Laboratório de Flavivírus (vigente até jan/2023).
Author
Affilliation
Abstract
The yellow fever (YF) vaccine is one of the safest and most effective vaccines currently available. Still, its administration in people living with HIV (PLWH) is limited due to safety concerns and a lack of consensus regarding decreased immunogenicity and long-lasting protection for this population. The mechanisms associated with impaired YF vaccine immunogenicity in PLWH are not fully understood, but the general immune deregulation during HIV infection may play an important role. To assess if HIV infection impacts YF vaccine immunogenicity and if markers of immune deregulation could predict lower immunogenicity, we evaluated the association of YF neutralization antibody (NAb) titers with the pre-vaccination frequency of activated and exhausted T cells, levels of pro-inflammatory cytokines, and frequency of T cells, B cells, and monocyte subsets in PLWH and HIV-negative controls. We observed impaired YF vaccine immunogenicity in PLWH with lower titers of YF-NAbs 30 days after vaccination, mainly in individuals with CD4 count <350 cells/mm³. At the baseline, those individuals were characterized by having a higher frequency of activated and exhausted T cells and tissue-like memory B cells. Elevated levels of those markers were also observed in individuals with CD4 count between 500 and 350 cells/mm³. We observed a negative correlation between the pre-vaccination level of CD8⁺ T cell exhaustion and CD4⁺ T cell activation with YF-NAb titers at D365 and the pre-vaccination level of IP-10 with YF-NAb titers at D30 and D365. Our results emphasize the impact of immune activation, exhaustion, and inflammation in YF vaccine immunogenicity in PLWH.
Publisher
MDPI
Citation
CAETANO, Diogo Gama et al. Impact of HIV-related immune impairment of Yellow Fever vaccine immunogenicity in people living with HIV-ANRS 12403. Vaccines, v. 12, n. 6, p. 1-17, 25 May 2024.DOI
10.3390/vaccines12060578ISSN
2076-393XNotes
Produção científica do Laboratório de Aids e Imunologia Molecular.Produção científica do Laboratório de Flavivírus (vigente até jan/2023).
Share